clinical trial · NCT05619367
A Compassionate Use (CU) Program of Odronextamab
Relapsed or Refractory (R/R) Follicular Lymphoma (FL)Diffuse Large B-Cell Lymphoma (DLBCL)B-Cell Non-Hodgkin Lymphoma (NHL)High-Grade B-Cell Lymphoma (HGBCL)Odronextamab
brief summary
Provide compassionate use of odronextamab
started
—
primary completion
—
completion
—
last updated
Oct 9, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol